These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media. Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279 [TBL] [Abstract][Full Text] [Related]
23. [Roentgen contrast media for intravascular use. Profile of side effects and pathophysiology]. Josephsen IL; Josephsen PG; Nissen F Ugeskr Laeger; 1987 Sep; 149(38):2522-5. PubMed ID: 2453962 [No Abstract] [Full Text] [Related]
24. [Experimental and clinical determination of renal size after intravenous and intra-arterial administration of ionic and non-ionic contrast media]. Helzel MV; Wolf GK; Prager P Rofo; 1985 Mar; 142(3):333-7. PubMed ID: 2984739 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic responses to contrast media. Lindgren P Invest Radiol; 1970; 5(6):424-45. PubMed ID: 5501848 [No Abstract] [Full Text] [Related]
26. Selection of intravascular contrast media in clinical radiology. Boijsen E Acta Radiol Suppl; 1983; 366():180-4. PubMed ID: 6433654 [TBL] [Abstract][Full Text] [Related]
27. Intravenous contrast media: use and associated mortality. Cashman JD; McCredie J; Henry DA Med J Aust; 1991 Nov; 155(9):618-23. PubMed ID: 1943961 [TBL] [Abstract][Full Text] [Related]
28. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage]. Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166 [No Abstract] [Full Text] [Related]
29. Contrast media and pain: hypotheses on the genesis of pain occurring on intra-arterial administration of contrast media. Hagen B; Klink G Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():50-6. PubMed ID: 6139080 [No Abstract] [Full Text] [Related]
30. Iodinated contrast media and the kidney. Weisbord SD Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313 [TBL] [Abstract][Full Text] [Related]
31. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage]. Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021 [No Abstract] [Full Text] [Related]
32. Comparative tolerability of contrast media used for coronary interventions. Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733 [TBL] [Abstract][Full Text] [Related]
33. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination. Jost G; Pietsch H; Lengsfeld P; Hütter J; Sieber MA Invest Radiol; 2010 May; 45(5):255-61. PubMed ID: 20375847 [TBL] [Abstract][Full Text] [Related]